Literature DB >> 9332364

Disrupted cholecystokinin type-A receptor (CCKAR) gene in OLETF rats.

S Takiguchi1, Y Takata, A Funakoshi, K Miyasaka, K Kataoka, Y Fujimura, T Goto, A Kono.   

Abstract

OLETF rats develop hyperglycemia, hyperinsulinemia and mild obesity, which is characteristic of human non-insulin-dependent diabetes mellitus (NIDDM). We cloned and sequenced the cholecystokinin type-A receptor (CCKAR) gene in the rats. Comparing the DNA sequences of the OLETF CCKAR gene and LETO CCKAR gene, normal gene, we found a deletion in the OLETF gene, 6847 bases in length, which was flanked by two 3-base-pair direct repeats (5'-TGT-3') at positions -2407/-2405 and 4441/4443, numbered according to the LETO gene sequence, one of which was lost. The promoter region, the first and second exons were missing in the mutant. The region upstream and downstream of the deletion, including exons 3, 4 and 5, was conserved between the two strains, and did not contain any base changes. We found that the gene mapped to chromosome 14 in rats. OLETF rats are the naturally occurring knockout animals with the homozygously disrupted CCKAR gene.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9332364     DOI: 10.1016/s0378-1119(97)00259-x

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  41 in total

1.  Cholecystokinin is up-regulated in obese mouse islets and expands beta-cell mass by increasing beta-cell survival.

Authors:  Jeremy A Lavine; Philipp W Raess; Donald S Stapleton; Mary E Rabaglia; Joshua I Suhonen; Kathryn L Schueler; James E Koltes; John A Dawson; Brian S Yandell; Linda C Samuelson; Margery C Beinfeld; Dawn Belt Davis; Marc K Hellerstein; Mark P Keller; Alan D Attie
Journal:  Endocrinology       Date:  2010-06-09       Impact factor: 4.736

2.  Decreased gastric mechanodetection, but preserved gastric emptying, in CCK-1 receptor-deficient OLETF rats.

Authors:  Bart C De Jonghe; Andras Hajnal; Mihai Covasa
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-05-25       Impact factor: 4.052

3.  Conditioned preference for sweet stimuli in OLETF rat: effects of food deprivation.

Authors:  Bart C De Jonghe; Andras Hajnal; Mihai Covasa
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-02-01       Impact factor: 3.619

Review 4.  Hyperphagia and obesity in OLETF rats lacking CCK-1 receptors.

Authors:  Timothy H Moran; Sheng Bi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

5.  Experimental models of non-alcoholic fatty liver disease in rats.

Authors:  Otto Kucera; Zuzana Cervinkova
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

6.  High-fat diet offsets the long-lasting effects of running-wheel access on food intake and body weight in OLETF rats.

Authors:  Pei-Ting Chao; Chantelle E Terrillion; Timothy H Moran; Sheng Bi
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-03-02       Impact factor: 3.619

7.  Cocaine- and amphetamine-regulated transcript (CART) peptide immunoreactivity in feeding- and reward-related brain areas of young OLETF rats.

Authors:  Simon Armbruszt; Hajnalka Abraham; Maria Figler; Tamas Kozicz; Andras Hajnal
Journal:  J Chem Neuroanat       Date:  2013-03-29       Impact factor: 3.052

8.  Functional compensation between cholecystokinin-1 and -2 receptors in murine paraventricular nucleus neurons.

Authors:  Shahid Mohammad; Tomoya Ozaki; Kouhei Takeuchi; Katsuya Unno; Kurumi Yamoto; Eri Morioka; Soichi Takiguchi; Masayuki Ikeda
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

9.  Pepsinogen secretion in cholecystokinin-1 receptor-deficient rats.

Authors:  Kenji Kanagawa; Hayato Nakamura; Makoto Otsuki
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

Review 10.  Rat models of human diseases and related phenotypes: a systematic inventory of the causative genes.

Authors:  Claude Szpirer
Journal:  J Biomed Sci       Date:  2020-08-02       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.